Bay Street News, 2024

SHENZHEN, China, May 23, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading […]

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]

• Vince Tyra a quitté ses fonctions de président et chef de la direction• Fin du processus de vente MONTRÉAL, […]

Vince Tyra has Stepped Down as President and CEO Sale Process has Ceased MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) — […]

CALGARY, Alberta, May 23, 2024 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of […]

CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors […]

MIAMI BEACH, Fla., May 23, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by […]

MONTRÉAL, May 23, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech […]

ELI-002 7P administered as a monotherapy was well tolerated and able to generate a ~100x mKRAS-specific expanded T cell response […]

— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 […]